Fundeni Clinical Institute

Bucharest, Bucharest 022328

2 studies enrolling now · 2 studies all time

What they study most

Relapsed or Refractory Multiple Myeloma (RRMM), Untreated, Unresectable, or Metastatic Colorectal Cancer

Studies at this site

• A Study to Compare the Efficacy and Safety of BMS-986393 Versus Standard Regimens in Adult Participants With Relapsed or Refractory and Lenalidomide-exposed Multiple Myeloma (QUINTESSENTIAL-2) — Recruiting now
• A Study to Evaluate the Safety and Efficacy of Pumitamig in Combination With Chemotherapy Versus Bevacizumab in Combination With Chemotherapy in Participants With Previously Untreated, Unresectable, or Metastatic Colorectal Cancer — Recruiting now